This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Unspecified Childhood Solid Tumor, Protocol Specific
and you are
under 21
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

RATIONALE: Studying samples of blood in the laboratory from patients with cancer receiving dactinomycin may help doctors learn how dactinomycin works in the body and how patients will respond to treatment. PURPOSE: This laboratory study is evaluating the pharmacokinetics of dactinomycin in young patients with cancer.

Provided treatments

  • Genetic: molecular genetic technique
  • Other: mass spectrometry
  • Other: pharmacological study
Tris trial is registered with FDA with number: NCT00900354. The sponsor of the trial is Children's Cancer and Leukaemia Group and it is looking for 50 volunteers for the current phase.
Official trial title:
Pharmacokinetics of Actinomycin D in Children With Cancer